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The Sensing Endotracheal Tube
James May1, Justin Phillips1, Saowrat Snidvongs2 and Panayiotis Kyriacou1
Abstract— Current pulse oximetry sensors are not very well
suited to use in anaesthetised patients as it has been shown
that during episodes of reduced peripheral circulation they do
not function correctly or fail all together [1], [2]. To address
this problem a new design for a photoplethysmography (PPG)
endotracheal (ET) sensor to monitor pulse rate and oxygen
saturation (SpO2) internally is presented. Flexible printed
circuit board (PCB) technology and miniature optoelectronic
components have been implemented and integrated with a
custom instrumentation system [3]. The sensor adheres and
conforms to the curvature of standard french-gauge 7 and 8
ET tubes at the point just above the inflatable cuff within the
laryngeal positioning markings. A 3D-modelled, optically clear,
soft silicon encapsulation electronically and thermally isolates
the electronic components whilst providing a smooth surface to
aid the insertion on the ET tube during standard intubation
procedures. A pilot study with 5 patients (3 Female, 2 Male),
undergoing abdominal and limb laproscopic procedures has
demonstrated the operation of the sensing ET tube, showing
good quality red and infra-red PPG signals. Preliminary signal
analysis reveals heart rate can be measured via PPG success-
fully, with saturation (SpO2) readings in close agreement with
the commercial monitors of 97.9 % (STD 0.2 %) and 98.6 %
(STD 0.8 %) respectively.
I. INTRODUCTION
Pulse oximeter probes, placed on the finger or earlobe
are used in all cases requiring general anaesthesia for mea-
surement of arterial oxygen saturation (SpO2). They are
not however ideally suited for use in anaesthetised patients,
as they have been shown to function incorrectly during
episodes of reduced peripheral circulation [1], [2]. Peripheral
blood flow is commonly disrupted during surgery, especially
during cardiac or other major procedures, by hypotension,
vasoconstriction, surgical blood loss or during weaning from
cardiopulmonary bypass. Furthermore the probe is suscepti-
ble to malpositioning during surgery, for example when the
patient is moved (or simply by being bumped or leant on by
members of the surgical team).
All of these events can produce incorrect SpO2 readings
[4], [5], [6], [7]. In severe cases, the pulse oximeter may
fail altogether, often at times when the patient is in a highly
critical condition, i.e. when monitoring is most needed. Lack
of continual reliable SpO2 readings compromises patient
safety while efforts to restore monitoring places an un-
welcome operational burden on the anaesthetist. Uninter-
rupted electronic records on patient information systems are
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increasingly important for effective postoperative care and
follow up of adverse events. There is therefore urgent need
for improved performance of pulse oximetry in these most
vulnerable patient groups.
Current intra-operative monitoring systems require a large
number of sensors placed on the body surface including ECG
electrodes, blood pressure cuffs, skin temperature sensors as
well as SpO2 probes. These sensors must operate through
a layer of skin, fat and muscle and as a result may suffer
from compromised accuracy and reliability. Sensors can also
be detached accidentally and require multiple connections to
the patient monitor using a large number of electrical cables
with the potential to be snagged or tripped over, leading to
monitoring failures. The connecting cables also complicate
and hinder the transfer of patients to theatre, positioning of
the patient, placement of surgical drapes as well as the actual
surgery.
Pulse oximetry is perhaps the most important development
in patient monitoring in the last forty years, however its
limitations are well known and well documented. Dark skin
pigmentation is known to affect light penetration causing
signal detection failures and in some cases, overestimation
of oxygen saturation [8]. Pulse oximeters are sensitive to
rapid limb movement (e.g. when shivering) [9]. If peripheral
perfusion is compromised, as can occur in vascular disease,
low cardiac output or simply because the patient is cold,
the pulse oximeter may fail [5]. Cardiopulmonary bypass is
especially challenging as a viable pulse signal is sometimes
absent for long periods as the patient re-warms [10].
Despite improvements in the accuracy of pulse oximetry
brought about by advances in signal processing over the last
decade or so [11], reliable and dependable SpO2 readings
still depend on adequate peripheral perfusion.
To overcome this limitation, Kyriacou et al. described an
internally placed reflectance pulse oximetry system in 2001
that allowed detailed investigation of SpO2 measurements
and the PPG signals, from which the SpO2 signals are
derived [12] from the oesophageal wall. The oesophagus was
chosen as a potentially suitable central monitoring site as it
is readily accessible in most anaesthetised patients and is
perfused directly by main arteries.
An initial clinical study, performed in patients undergoing
general anaesthesia showed that reliable signals could be
obtained in all subjects, and that the optical pulse signals
were significantly larger in amplitude than those obtained
from a probe of similar geometry clipped onto the finger. A
follow-on clinical study [13], [14] investigated and compared
oesophageal and finger PPG signals and SpO2 measurements
in 49 patients undergoing hypothermic cardiothoracic by-
pass surgery. Measurable PPG traces at red and infrared
wavelengths were obtained in the oesophagus in all 49
patients. Of the 49 patients included in the study, it was
found that five patients had one or more periods of at
least ten consecutive minutes during which the commercial
finger pulse oximeter failed to display SpO2 values, despite
being correctly positioned on the finger. Conversely, the
oesophageal pulse oximeter operated successfully throughout
these periods.
Internal sensors offer significant improvements in accuracy
and reliability over surface sensors. The wall of the trachea
is so-far an unexplored but readily accessible and highly
vascularised tissue bed and offers a single central site from
which a wide range of clinical variables may be measured.
It has been proposed that a new, novel flexible PPG sensor,
able to detect the required signals needed for SpO2 and pulse
rate measurements, be utilised to investigate whether the PPG
signals from the tracheal wall are suited to this monitoring
modality.
II. METHODS
A. Endotracheal Sensor
A custom, flexible, printed circuit board (PCB) and sili-
cone rubber covering were modelled in SolidWorks (Dassault
Syste`mes, France). The requirement of the sensor to be
flexible so that it could be attached to the curved surface of a
standard endo-tracheal tube (adult sizes 7 and 8) meant that
compromises had to be made on component placement and
geometry, most notably the components had to be arranged
linearly, with the red LED closer to the photo diode. The
centre-to-centre distances of the red and infra-red LED to
the photodiode were 7 mm and 13 mm respectively. This
may affect the accuracy of SpO2 measurements as the light
is not passisng through the exact same tissue bed. A 3D
projection of the sensor head is shown in figure 1. Overall
dimensions of the the sensor, including the silicone covering
are 435 x 29 x 1.3 mm (L x W x H).
The PCB was manufactured on a polyester film with a
thickness of 75 µm (Melinex, DuPont, USA) with a sensor
interface at the distal end incorporating one 660 nm (red)
and one 940 nm (infra-red) LED (KP-3216 series LEDs,
Kingbright, Taiwan) and a broad spectrum (400 - 1100 nm)
high sensitivity PIN photo diode (VEMD6010X01,Vishay
Semiconductors, USA). The components were bonded to the
PCB with a flexible epoxy resin (Light Weld 488-Series,
DYMAX, USA) and electrically and thermally insulated
with the custom 3D-modelled, clear, silicone rubber covering
(Silpuran 6000, Wacker Chemie, Germany). The circuit
board was insulated with a UV-cured flexible ink (Electrodag
452SS, Henkel, Germany) and terminated at the proximal
end by a 5-pin connector (Crimpfelx, Nicomatic, France).
The completed sensors were designed to be single use
devices to ensure maximum patient safety and prior to
trials were cleaned, sealed in blister packs and chemically
sterilised (ETO procedure) by a specialised sterilisation com-
pany. The sensors were also put under a bio-burden test to
check for any harmful pathogens or contaminants.
39 mm
29 mm
Flexible PCB
Silicone Covering
Raised Optical Window
25 x 4.25 x 1.3 mm
(L x W x H)
Fig. 1. A 3D model of the distal (sensing) end the ETT sensor, depicting the
silicone covering and optical window/cavity for the LEDs and photo-diode.
B. Photoplethysmographic Instrumentation
Custom back-end PPG instrumentation has been developed
[3] to drive the active elements of the sensor and process the
raw signals ready for data storage on a laptop computer.
The PPG device, named ZenPPG by its’ creators, has the
ability to drive multiple physiological sensors and can be
customised for nearly any clinical trial or in vivo study.
The current configuration, chosen for these clinical trials
of the ETT sensor, incorporates two single PPG ports, each
with the capability of driving two LEDs and sensing from
one photo diode. One port will be used for driving the
custom ETT sensor, whilst the other is designed to drive
a commercial probe (Masimo, USA) for the purpose of
comparison of PPGs from a traditional peripheral location.
This is connected to an isolation data-acquisition (DAQ) card
(National Instruments, USA) which is in turn connected to a
laptop computer running the DAQ software and data-logging
software (LabVIEW, National Instruments, USA).
The LabVIEW virtual instrument (VI) developed to run
ZenPPG acquires data at a rate of 1 kHz, and can control
the individual brightness of individual LEDs on the attached
sensors. Data is saved in the form of a text file, and includes
the capability to manually stamp the data file with time-
markers to aid in the synchronisation of data with events in
the clinical trial, i.e. patient movement or the noting down
of specific vital readings from the commercial monitors.
C. Pilot Investigation
The planned initial clinical trial has been set up to establish
whether or not PPG signals can be obtained from the tracheal
wall, and to assess their suitability in pulse rate measurement
and SpO2 estimation. This will be compared with the same
readings as taken by the commercial monitors, as well as
with a commercial sensor (Masimo, USA) attached to the
ZenPPG system.
Five patients (3 Female, 2 Male), mean age 46.6 years
(std 16.7 years), mean weight 75.7 kg (std 20.6 kg), were
recruited from surgical lists at Bart’s NHS Trust, London UK.
Each patient was recruited into the study by a GCP (Good
Clinical Practice) trained clinical member of the investigation
team. Each recruit was given an information sheet explaining
the nature of the study and adequate time to decide (48 hours)
if they wanted to participate. A consent form was acquired
from willing recruits and after the anaesthetisation procedure
an endo-tracheal tube with a pre-attached ETT sensor was
placed into the trachea as per normal intubation procedure.
Prior to intubation the sensor was checked for operability
(sensor attached to ZenPPG and LEDs operated by software),
then adhered to the tube just above the inflatable cuff just
past the laryngeal guidance markers. The sensor was situated
on the inside curve of the tube so that the sensor would face
anteriorly. The sensor was switched on once the patient was
situated on the operating table and in a secure position.
Recordings commenced from a time when adjustments to
LED intensities were made so that PPG signals from the ETT
sensor could be observed on the laptop display from both the
infra-red and red channels. Recordings were complimented
with manually-entered time markers that were taken approx-
imately every minute. Each marker was accompanied by an
SpO2 and pulse rate reading from the clinical monitors for
comparison during data analysis.
Recordings were ceased after 1 hour. The ETT sensor was
detached from ZenPPG but left in-situ for the remainder
of the surgical procedure. The sensor was only removed
once the Anaesthetist removed the endo-tracheal tube when
waking the patient as is normal procedure.
III. RESULTS
Recorded signals were down-sampled and filtered using
a 3325th order band-pass FIR filter (0.3 - 5 Hz) in Matlab
(MathWorks Inc, USA). Signals were visually inspected and
a 5 minute window of good quality signals was selected for
preliminary analysis from each patient. Figure 2 shows a
typical 20 second trace of the filtered PPG signals observed
from the ETT sensor. Notice that the red and infra-red signals
display similar amplitude. Signals were then passed through
a custom algorithm to normalise and measure the amplitude
of the signals.
Normalizing the signals and calculating the amplitude
for these 5 minute signals shows that the red and infra-
red signals have a mean amplitude of 205.6 mV (STD
292.0 mV) and 437.3 mV (STD 628.3 mV) respectively
from the ETT sensor. The commercial sensor attached to
the ZenPPG, taking measurements from a periphery location
(PER) conversely shows signals with a lesser degree of
variance at 103.8 mV (STD 53.4 mV) and 214.4 mV (STD
109.3 mV) respectively for the red and infra-red signals.
Figure 3 shows the bar-plot of the amplitude analysis form
the individual patients. The large variance seen in the ETT
signals as opposed to the PER signals is largely due to the
results from the 3rd volunteer who displayed much greater
AC amplitudes than the other subjects at 719.4 mV (STD
83.4 mV) and 1544.0 mV (STD 229.3 mV), red and infra-
red respectively at the ETT sensor. Interestingly the same
patient displayed the smallest normalised amplitude at the
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Fig. 2. Red and Infra-red PPG signals from the ETT sensor, 20 second
sample, showing good definition of the main PPG peaks in both plots.
Average pulse rate = 67 bpm.
periphery location at 61.5 mV (STD 31.74 mV) and 132.7
mV (STD 78.4 mV) for the red and infra-red signals.
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Fig. 3. Mean normalised amplitudes with standard deviation bars for the
ETT sensor (top) and PER sensor (bottom), total signal length per patient
= 5 minutes.
Consideration now has to be taken for what these signals
can reveal about the health of the patient. All signals were
analysed in 10-second segments, and either passed through a
custom algorithm that calculated pulse rate via fast-Fourier-
transform method and SpO2 using the method set out in [15]
and shown in equation 1 and 2.
SpO2 = 110−25R (1)
where...
R=
ACred/DCred
ACir/DCir
(2)
The results were compared with the timestamps from the
original data file, and each patient over the 5 minute window
had between 5 and 7 time-stamps available in that time
period. The mean vital statistics for pulse rate and oxygen
saturation (n = 30) show good agreement with the clinical
readings at 63.2 bpm (STD 12 bpm) and 97.9 % (STD 0.6
%) vs. 63.0 bpm (STD 12.4 bpm) and 98.6 % (STD 0.8 %)
for the ETT sensor and the clinical readings respectively.
The reference peripheral sensor meanwhile confirms this
observation at 63.2 bpm (STD 11.6 bpm) and 97.9 % (STD
0.2 %) for the same time period. The observed means for
each patient can be seen in figure 4.
Fig. 4. Mean vital statistics for each patient with all three sensors, SpO2
top, and heart rate (PPG-derived) bottom.
IV. DISCUSION
The filtered signals from the ETT sensor, before normal-
isation, regularly displayed red PPG signals of similar or
sometimes greater amplitude than the infra-red signals. For
sensors where the estimated light path of the illuminating
light is thought to be equal for both wavelengths, the infra-
red signal AC amplitude is normally observed to be 2 - 2.5
times greater. Generally it is not considered best practice to
design a sensor where the light path for both signals is differ-
ent as different areas of differently-oxygenated tissues may
be illuminated that could affect the overall SpO2 estimation.
As pointed out in section II-A a compromise had to be
made on component selection and placement due to the
materials being used and the components available. When the
signal is normalised, however, the expected average red/infra-
red ratio between the AC amplitudes is observed in all
patients.
In this trial it has been shown that with normalisation of
the AC signals the estimated SpO2 is very close to the clinical
reading, and on average 0.7 % less, with a similar variation.
This is confirmed by the reference probe connected to the
same measurement system, and therefore any inaccuracy
in the readings may solely be down either to the sensor
placement or the algorithms used for SpO2 estimation. Since
the commercial monitors all use proprietary algorithms it is
impossible to know what averaging is being done on the
observed SpO2 value, and therefore it may the case that
this sensor with this component configuration needs specific
calibration.
Heart rate estimates do not rely on specific areas of tissue
being illuminated, except that an arterial pulsatile component
is present so that a frequency analysis can be performed via
FFT so that HR can be calculated. In this regard the ETT
sensor has shown to be as accurate as the commercial sensor,
with a slightly higher variance, but this may be due only to
the specific averaging routine carried out on the HR estimate
on the commercial monitors.
The third patient was observed to have much greater ETT
signal amplitudes than the other 4 patients. Whilst it is de-
sired that large amplitude signals are acquired from subjects,
it is not necessarily translatable to vital sign monitoring that
is either more accurate or with less variance. In-fact the
individual SpO2 estimation for this particular subject was
on average -1.9 % lower, whilst the remaining subjects were
-1 % or less.
V. CONCLUSION
A larger pilot study to confirm the accuracy and produce
the efficacy needed to prove this technology is needed. In
this pilot investigation, however, the required PPG signals
have been proven to be of suitable quality to calculate heart
rate and SpO2 effectively.
Vital-signs monitoring from the trachea using specially de-
signed sensors appears to be a viable alternative to traditional
monitoring solutions, and has the potential to compliment
or replace traditional sensors in clinical (surgical or ICU)
use where traditional sensors may be known to present
difficulties during placement or during use.
REFERENCES
[1] H. Gehring, C. Hornberger, H. Matz, E. Konecny, and P. Schmucker,
“The effects of motion artifact and low perfusion on the performance
of a new generation of pulse oximeters in volunteers undergoing
hypoxemia,” Respiratory Care, vol. 47, no. 1, pp. 48–60, 2002.
[2] D. L. Reich, A. Timcenko, C. A. Bodian, J. Kraidin, J. Hofman,
M. DePerio, S. N. Konstadt, T. Kurki, and J. B. Eisenkraft, “Predictors
of pulse oximetry data failure,” Anesthesiology, vol. 84, no. 4, pp.
859–864, 1996.
[3] V. Rybynok, J. M. May, K. Budidha, and P. A. Kyriacou, “Design and
development of a novel multi-channel photoplethysmographic research
system,” in 2013 IEEE Point-of-Care Healthcare Technologies (PHT),
Jan 2013, pp. 267–270.
[4] J. W. Severinghaus and M. J. Spellman, “Pulse oximeter failure thresh-
olds in hypotension and vasoconstriction,” Anesthesiology, vol. 73,
no. 3, pp. 532–537, 1990.
[5] S. DeMeulenaere, “Pulse oximetry: Uses and limitations,” The Journal
for Nurse Practitioners, vol. 3, no. 5, pp. 312–317, 2007.
[6] K. Yamaura, K. Irita, T. Kandabashi, K. Tohyama, and S. Takahashi,
“Evaluation of finger and forehead pulse oximeters during mild
hypothermic cardiopulmonary bypass,” Journal of Clinical Monitoring
and Computing, vol. 21, no. 4, pp. 249–52, 2007.
[7] S. J. Barker, J. Hyatt, N. K. Shah, and Y. J. Kao, “The effect of
sensor malpositioning on pulse oximeter accuracy during hypoxemia,”
Anesthesiology, vol. 79, no. 2, pp. 248–54, 1993.
[8] J. N. Adler, L. A. Hughes, R. Vivilecchia, and J. Camargo, C. A.,
“Effect of skin pigmentation on pulse oximetry accuracy in the emer-
gency department,” Academic emergency medicine : official journal
of the Society for Academic Emergency Medicine, vol. 5, no. 10, pp.
965–70, 1998.
[9] J. A. Langton, “Shivering and pulse oximeter function,” Anaesthesia,
vol. 47, no. 8, p. 711, 1992.
[10] H. Palve and A. Vuori, “Minimum pulse pressure and peripheral
temperature needed for pulse oximetry during cardiac surgery with
cardiopulmonary bypass,” Journal of cardiothoracic and vascular
anesthesia, vol. 5, no. 4, pp. 327–30, 1991.
[11] J. M. Goldman, M. T. Petterson, R. J. Kopotic, and S. J. Barker,
“Masimo signal extraction pulse oximetry,” Journal of Clinical Mon-
itoring and Computing, vol. 16, no. 7, pp. 475–83, 2000.
[12] P. A. Kyriacou, A. R. Moye, D. M. Choi, R. M. Langford, and D. P.
Jones, “Investigation of the human oesophagus as a new monitoring
site for blood oxygen saturation,” Physiological Measurement, vol. 22,
no. 1, pp. 223–32, 2001.
[13] P. A. Kyriacou, S. Powell, R. M. Langford, and D. P. Jones, “In-
vestigation of oesophageal photoplethysmographic signals and blood
oxygen saturation measurements in cardiothoracic surgery patients,”
Physiological Measurement, vol. 23, no. 3, pp. 533–45, 2002.
[14] P. A. Kyriacou, S. L. Powell, D. P. Jones, and R. M. Langford,
“Evaluation of oesophageal pulse oximetry in patients undergoing
cardiothoracic surgery,” Anaesthesia, vol. 58, no. 5, pp. 422–7, 2003.
[15] J. G. Webster, Design of pulse oximeters. Institute of Physics Pub,
1997.
